Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alaa A Alotaibi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cureus|February 4, 2026
Sixteen-Year Interval CT Comparison in Chiari II Malformation After Early Ventriculoperitoneal Shunting: Marked Ventricular Improvement and a Prolonged Seizure-Free IntervalAhmed H Khird, Alaa A Alotaibi
CNS Drugs|April 2, 2021
Sphingosine 1-Phosphate Receptor Modulators for Multiple SclerosisReshmi Roy, Alaa A Alotaibi, Mark S Freedman
Cureus|January 9, 2023
Correction: Association Between Body Mass Index and Response to Disease-Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis at King Abdulaziz University Hospital: A Retrospective StudyMohammed N Aljehani, Ziyad I Alshehri, Faisal A Alharbi, et al.
Cureus|December 22, 2022
Association Between Body Mass Index and Response to Disease-Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis at King Abdulaziz University Hospital: A Retrospective StudyMohammed N Aljehani, Ziyad I Alshehri, Faisal A Alharbi, et al.
Multiple Sclerosis and Related Disorders|July 19, 2025
Exploring the role of inflammatory cytokines in multiple sclerosis: A comparative perspectiveEbtisam A Alofi, Mada A Agab, Alaa A Alotaibi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 20, 2025
Post-vaccinal seronegative autoimmune encephalitis following recombinant zoster vaccination in two immunocompetent patientsTariq A Madani, Abeer A Khoja, Ahmad R Abuzinadah, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cureus|February 4, 2026
Sixteen-Year Interval CT Comparison in Chiari II Malformation After Early Ventriculoperitoneal Shunting: Marked Ventricular Improvement and a Prolonged Seizure-Free IntervalAhmed H Khird, Alaa A Alotaibi
CNS Drugs|April 2, 2021
Sphingosine 1-Phosphate Receptor Modulators for Multiple SclerosisReshmi Roy, Alaa A Alotaibi, Mark S Freedman
Cureus|January 9, 2023
Correction: Association Between Body Mass Index and Response to Disease-Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis at King Abdulaziz University Hospital: A Retrospective StudyMohammed N Aljehani, Ziyad I Alshehri, Faisal A Alharbi, et al.
Cureus|December 22, 2022
Association Between Body Mass Index and Response to Disease-Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis at King Abdulaziz University Hospital: A Retrospective StudyMohammed N Aljehani, Ziyad I Alshehri, Faisal A Alharbi, et al.
Multiple Sclerosis and Related Disorders|July 19, 2025
Exploring the role of inflammatory cytokines in multiple sclerosis: A comparative perspectiveEbtisam A Alofi, Mada A Agab, Alaa A Alotaibi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 20, 2025
Post-vaccinal seronegative autoimmune encephalitis following recombinant zoster vaccination in two immunocompetent patientsTariq A Madani, Abeer A Khoja, Ahmad R Abuzinadah, et al.
Pageof 1